Checchi Capital Advisers, LLC Amgen Inc Transaction History

Checchi Capital Advisers, LLC

$1.71 Billion
Q4 2024

A detailed history of Checchi Capital Advisers, LLC transactions in Amgen Inc stock. As of the latest transaction made, Checchi Capital Advisers, LLC holds 6,701 shares of AMGN stock, worth $1.95 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

6,701

Previous 6,657 0.66%

Holding current value

$1.95 Million

Previous $2.14 Million 18.56%

% of portfolio

0.1%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$258.78 - $328.31 $11,386 - $14,445	44 Added 0.66%	6,701 $1.75 Million
Q3 2024 Nov 04, 2024	SELL	$309.38 - $337.38 $56,925 - $62,077	-184 Reduced 2.69%	6,657 $2.14 Million
Q2 2024 Jul 26, 2024	BUY	$262.75 - $319.31 $26,537 - $32,250	101 Added 1.5%	6,841 $2.14 Million
Q1 2024 Apr 25, 2024	SELL	$268.87 - $324.56 $64,797 - $78,218	-241 Reduced 3.45%	6,740 $1.92 Million
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $25,314 - $28,557	99 Added 1.44%	6,981 $2.01 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $39,357 - $48,862	-180 Reduced 2.55%	6,882 $1.85 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $35,783 - $42,312	-167 Reduced 2.31%	7,062 $1.57 Million
Q1 2023 May 05, 2023	SELL	$225.79 - $275.2 $37,255 - $45,408	-165 Reduced 2.23%	7,229 $1.75 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $204,523 - $259,871	-893 Reduced 10.78%	7,394 $1.94 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $11,447 - $12,910	51 Added 0.62%	8,287 $1.87 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $293,924 - $327,086	1,274 Added 18.3%	8,236 $2.04 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $137,263 - $151,848	626 Added 9.88%	6,962 $1.68 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $16,109 - $18,435	-81 Reduced 1.26%	6,336 $1.43 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $18,255 - $21,388	-86 Reduced 1.32%	6,417 $1.37 Million
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $78,249 - $86,811	-335 Reduced 4.9%	6,503 $1.59 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $17,530 - $20,429	-79 Reduced 1.14%	6,838 $1.7 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $13,199 - $15,717	-61 Reduced 0.87%	6,917 $1.59 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $18,537 - $20,615	-79 Reduced 1.12%	6,978 $1.77 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $58,749 - $72,093	-297 Reduced 4.04%	7,057 $1.66 Million
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $116,269 - $154,204	638 Added 9.5%	7,354 $1.49 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $60,547 - $77,824	320 Added 5.0%	6,716 $1.62 Million
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $174 - $208	-1 Reduced 0.02%	6,396 $1.24 Million
Q2 2019 Aug 06, 2019	SELL	$166.7 - $195.41 $71,347 - $83,635	-428 Reduced 6.27%	6,397 $1.18 Million
Q1 2019 May 09, 2019	SELL	$180.87 - $203.88 $41,600 - $46,892	-230 Reduced 3.26%	6,825 $1.3 Million
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $65,829 - $76,844	-369 Reduced 4.97%	7,055 $1.37 Million
Q3 2018 Oct 29, 2018	BUY	$185.29 - $208.89 $174,357 - $196,565	941 Added 14.51%	7,424 $1.54 Million
Q2 2018 Aug 06, 2018	BUY	$166.05 - $186.51 $27,398 - $30,774	165 Added 2.61%	6,483 $1.2 Million
Q1 2018 May 01, 2018	SELL	$169.43 - $198.0 $186,034 - $217,404	-1,098 Reduced 14.81%	6,318 $1.08 Million
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $175,372 - $195,945	1,039 Added 16.29%	7,416 $1.29 Million
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $1.07 Million - $1.22 Million	6,377	6,377 $1.19 Million

Others Institutions Holding AMGN

# of Institutions

3,144

Shares Held

415M

Call Options Held

8.2M

Put Options Held

6.65M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Checchi Capital Advisers, LLC with notifications on news.

Account

Checchi Capital Advisers, LLC Amgen Inc Transaction History